Headlands Research completes acquisition of Pharmasite Research, expanding expertise in mental health and CNS research
Acquiring Company
Headlands Research
Acquired Company
Pharmasite Research
Description
Headlands Research, a multinational network of clinical trial sites, has completed the acquisition of Pharmasite Research, an established clinical trial site dedicated to research in mental illness and disorders of the central nervous system (CNS). This strategic acquisition enhances Headlands Research's therapeutic expertise in key competencies, reinforcing its commitment to advancing innovative medical therapies.
Quick answer
Headlands Research is acquiring Pharmasite Research, announced March 1, 2024. Headlands Research is based in Lake Worth, Florida, United States.
- How much did Headlands Research pay for Pharmasite Research?
- The deal value was not disclosed.
- What does Headlands Research do?
- Headlands is a clinical trial firm that provides comprehensive services for clinical research.
- Where are Headlands Research and Pharmasite Research based?
- Headlands Research is based in Lake Worth, Florida, United States. Pharmasite Research is based in Baltimore, Maryland, United States.
- Who are the decision-makers at Headlands Research?
- Fundz holds 1 contact at Headlands Research. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions, $13B (April 5, 2024)
- XOMA Corporation successfully acquires Kinnate Biopharma Inc. (April 3, 2024)
- Reverba completes acquisition of Six Degrees Worldwide Inc. to integrate medical communication services (April 3, 2024)
- KARL STORZ SE & Co. KG announces non-binding acquisition proposal and exclusivity arrangement with Asensus Surgical, Inc. (April 3, 2024)
- Juvisé Pharmaceuticals acquires rights to MS therapy Ponvory outside North America (April 2, 2024)
- XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right (February 16, 2024)
Who to call at Headlands Research, and when
When Headlands Research changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Headlands Research raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Headlands Research, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Headlands Research. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Headlands Research makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Pharmasite Research?
Pharmasite Research was acquired by Headlands Research, based in Lake Worth. The deal was reported on March 1, 2024. Headlands is a clinical trial firm that provides comprehensive services for clinical research. They specialize in supporting biopharmaceutical companies through the entire clinical development process. Headlands Research is privately held and operates in Healthcare.
When did Headlands Research acquire Pharmasite Research?
Headlands Research's acquisition of Pharmasite Research was reported on March 1, 2024. Headlands Research, a multinational network of clinical trial sites, has completed the acquisition of Pharmasite Research, an established clinical trial site dedicated to research in mental illness and disorders of the central nervous system (CNS). Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Pharmasite Research do?
Pharmasite Research is an established clinical trial site dedicated to research in mental illness and disorders of the central nervous system (CNS). It brings over 20 years of clinical research expertise in the areas of mental health and CNS. It is privately held, operating in Biotechnology, and is based in Baltimore.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.